Validation of a Model for Predicting Magnesium Concentration in Women with Preeclampsia: A Retrospective Cohort Study

CONCLUSIONS: Zuspan regimen is very safe, but slow to reach therapeutic concentrations-despite efforts of individual titration. Success rate is lower in heavy women, which is of particular importance considering their predisposition to develop preeclampsia. The validated pharmacokinetic model performs well and may be used to individually tailor treatment from the outset.PMID:38504794 | PMC:PMC10950413 | DOI:10.1155/2024/1178220
Source: Journal of Pregnancy - Category: OBGYN Authors: Source Type: research